APTEEUS 

Biotech company specialized in drug repurposing for rare diseases

OWNER

Terence Beghyn (See Profile)


Sector

Personalised medicine

Stage

Prototyping, preclinical

Country

France


2 derisked candidate drugs for addressing life-threatening disorders at preclinical stage.

Discovery engine generating turnover and new opportunities of development

Solid IP portefolio

Status

Pending

IP Type

Patent

Time

–

Countries

Belgium
Canada
China
Denmark
Finland
France
Germany
Italy
Japan
Netherlands
Spain
Switzerland
USA
United Kingdom

Coverage

The new use of active ingredient in treating peroxisomopathies

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 10th of March 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar